Intestinal stem cells (ISCs) derived from a patient’s own cells have garnered significant attention as a new alternative for treating intractable intestinal diseases due to their low risk of rejection. However, clinical application has been…
Continue Reading
News Source: medicalxpress.com
Leave a Reply